Retrolaminar Block Versus Tab Block in Abdomioasty
Comparison Between US Guided Retrolaminar Block and Transversus Abdominis Plane Block for Post Operative Analgesia in Patient Undergoing Abdominal Plastic Surgery
1 other identifier
interventional
90
1 country
1
Brief Summary
The aim of the study is to compare the analgesic efficacy of Us guided retrolaminar block versus transversus abdominis plane block in patient under going abdominal plastic surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2024
CompletedFirst Submitted
Initial submission to the registry
February 11, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedFebruary 20, 2024
February 1, 2024
1.8 years
February 11, 2024
February 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Total dose of morphine consumption in the first postoperative 24hours
Total dose of morphine consumption in the first postoperative 24hours
First 24hours
Study Arms (2)
Retrolaminar block in abdominal plastic surgery
ACTIVE COMPARATORIn first group induction done with general anaesthia then Patient will receive bilateral us guided rertrolaminar block then bubivacane ,25%with dexa methasone 4mg as addiditive injected on the lamina at dose 20ml injected each side
Tab block as post operative analgesia in abdominal plastic surgery
ACTIVE COMPARATORIn secound group after general anaesthia induction bilateral us guided tap block with ,25%bupivacaine with dexamethasone 4mg as addiditve injected on the lamina at doses 20ml in each side
Interventions
i inject 20ml bupivacine either 4mg dead in each side
Eligibility Criteria
You may qualify if:
- \- 90patients aged 18/65years of both sexes and asa physical status one two and three undergoing abdominal plastic surgery
You may not qualify if:
- patient refusal Patient taking analgesia of chronic illness or have history of substance abuse Patient who are unable to describe their post operative pain Patient with history of coagulabathy Un cooperative patient Patient with known allergy to study drug Patient with infection at site needle puncture Patient with decompensated hepatic renal respiratory or cardiac disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
TantaU U
Tanta, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hadeel Elsagheer
Tanta University
Central Study Contacts
Tayseer Abdelrahman
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Elwakeel street qsm1
Study Record Dates
First Submitted
February 11, 2024
First Posted
February 20, 2024
Study Start
January 15, 2024
Primary Completion
October 15, 2025
Study Completion
December 15, 2025
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share